Values First Advisors, Inc. Karuna Therapeutics, Inc. Transaction History

Values First Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	SELL	$161.01 - $317.85 $10,948 - $21,613	-68 Reduced 1.66%	4,039 $1.28 Million
Q3 2023 Nov 08, 2023	SELL	$164.66 - $218.08 $13,666 - $18,100	-83 Reduced 1.98%	4,107 $694,000
Q2 2023 Aug 02, 2023	SELL	$176.32 - $240.22 $17,984 - $24,502	-102 Reduced 2.38%	4,190 $908,000
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $46,140 - $58,446	286 Added 7.14%	4,292 $779,000
Q4 2022 Jan 20, 2023	SELL	$191.53 - $236.82 $238,454 - $294,840	-1,245 Reduced 23.71%	4,006 $0
Q3 2022 Dec 02, 2022	SELL	$123.79 - $277.42 $61,399 - $137,600	-496 Reduced 8.63%	5,251 $1.18 Million
Q2 2022 Jul 20, 2022	SELL	$93.97 - $143.33 $39,091 - $59,625	-416 Reduced 6.75%	5,747 $727,000
Q1 2022 May 03, 2022	SELL	$98.9 - $132.37 $23,439 - $31,371	-237 Reduced 3.7%	6,163 $781,000
Q4 2021 Mar 10, 2022	BUY	$110.64 - $159.4 $708,096 - $1.02 Million	6,400 New	6,400 $838,000
Q3 2021 Nov 15, 2022	BUY	$101.2 - $125.87 $105,652 - $131,408	1,044 Added 18.17%	6,791 $831,000
Q2 2021 Nov 15, 2022	BUY	$107.45 - $135.95 $509,742 - $644,946	4,744 Added 282.05%	6,426 $732,000
Q1 2021 Nov 15, 2022	SELL	$95.46 - $133.08 $388,044 - $540,970	-4,065 Reduced 70.73%	1,682 $202,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Values First Advisors, Inc. with notifications on news.